Oncolytics Biotech Inc T.ONC

Lets try & stay on topic, this is a great and detailed repor

[canadafan]

This report shows why the SP ( in trading) has little significance.
The anlaysts lookinto the business model.
His $8.50 CDN is one of the most consrvative & does not include any PanCan income.
worth a read
https://leedejonesgable.com/wp-content/uploads/ONC_2023_10_17.pdf

[lonc17]

Canadafan invests his hard earned savings in a stock and then honestly believes that the SP is not significant. One can only imagine the amount he has lost on his investment in ONC (and other companies) with this mindset over the past couple of decades. Not once in the past 24 years has an analyst (or Canadafan) correctly predicted an uptick in ONC's shareprice. ONC's shares are in the

[Azzak34]

Of all the drivel that is posted on here, this incoherent diatribe is not only full of malinformed nonsense its also full of inaccuracies.  You are, and have always been, another whinge on here. Sell whatever shares you have, spare yourself the angst and join Fox in the "wealthy, well educated" soft and weak men. "We are not descended from cowards" is a quote that

[Lesalpes29]

An other good report! We need an other fireside chat! It's a joke to begin a green friday! Fingers crossed. Have a great day wherever you are,

[Buckhenry]

To Anyone that would use anything on this or stocktwits site to make decision to buy or sell I have some oceanfront property in Arizona I'm selling cheap !!!

[Azzak34]

Is that right Bigot. Then why try so hard? 

[Buckhenry]

Many biotechs flounder and don't ever produce. That's why the institutions tend to avoid them especially when you look at the price fluctuations we have seen here. In many respects they are treated like playing the roulette wheel. Don't gamble with money you can't afford to lose. Now... I do think the data is promising but again many biotechs have been here and never produced. So

[askretka]

Agreed Canadafan its a very detailed report. The company he works for is Leedejonesgable that brokered the 15 mill US financing. He's quite conservative and was the first analyst to add Pancreatic Cancer to his analysis way before anyone else. He hasn't written a report for awhile due to the fact that his company had done the financing I'm guessing and he had knowledge that he wasn

[itntdf]

but will we live long enough? our model assumes that pelareorep will advance through pivotal Phase III testing in at least two distinct oncology markets – HER2-negative/hormone receptor-positive metastatic breast cancer on which we have commented before, and advanced, metastatic pancreatic cancer that formed the basis of our analysis above – and that pelareorep can be approved and launched during

[Lesalpes29]

2028-2030 Matt will probably push it between 2038-2040... remember it's friday! GL

[fox7mf]

Exactly De_man, BD developments need to happen now...who's waiting around much longer? The cheerleaders can wax poetic about Coffey until the cows come home, but he has to act soon...pass this off to a major.

[inthno]

The Report is very detailed and really all should read it even though timelines are pushed out for updates in the phase 3 setting. And it would appear from what I read but is open to interpretation that the report does include possible revenue from Panc. Hopefully updates sooner than a few months or quarters. It should be by our 3 quarterly webcast at the latest IMO as they have had ample time for

[fox7mf]

If updates take a few quarters this will be trading at $0.25. The constant drip in SP could be disgruntled shareholders who piled in after PanCan news and who are frustrated with the lack of business execution & missed deadlines. We can't always attribute a negative day to those dastardly MM's. As for FUD...Coffey creates enough of that on his own.

[JohnnyYeg]

25 cents?? C'mon Foxy - that is ridiculous and uncalled for. As for Coffey, I will ask again, what is he supposed to do? If he is in negotations of anykind he can't report on anything. As far as any followup to PanCAN and the GOBLET trials, those are being presented at ESMO which have embargos on any new releases before the presentations. If there is anything to be "reported" on

[fox7mf]

Under promise over deliver, that is what he should do. Shareholders, imo, are jumping ship. As for updates, if they take many quarters, this will tank.

[Lesalpes29]

MM for Mislead Matt. Let's go Matt, a friday afternoon NR just to give us a big smile. 

[13X2413]

Apparently this target price is a secret, otherwise, this wouldn't be a $2 stock. This is getting ridiculous. Another day of frustration.  I'm dying to know what these operational highlights are going to be on Nov 3 seeing that this has dropped app. 50% in a few months.